DAXOR CORP

DXR · Nasdaq · SIC : · Market Cap: $0.1B · 750 employees
153
SEC Filings
$10.06
Close 2026-06-01
750
Employees

Business Summary

Daxor Corporation is a medical device manufacturing company providing biotechnology services. Its primary product is the BVA-100 Blood Volume Analyzer, used with the Volumex single-use radiopharmaceutical injection and collection kit to measure human blood volume with 98% accuracy within 60-90 minutes. The company also offers cryobanking services for blood and semen storage through subsidiaries Scientific Medical Systems and Idant, and manufactures next-generation BVA-100 models at its Oak Ridge, Tennessee facility.

Latest Stock Quote

DXR 2026-06-01 $10.06 O:$9.61 H:$10.47 L:$9.61 Vol:0.0M VWAP:$10.0922
origin leaf: 47892fbc60169457684c9baf9cf639bd76b9d00330b5dd72a6b056ea58159deb

Next Earnings

Q2 FY2026 — expected 2026-08-12

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2012-03-282011-12-310001019056-12-000401EDGAR55K words
2011-03-292010-12-310001019056-11-000367EDGAR—
2010-03-292009-12-310001019056-10-000373EDGAR—
2009-03-232008-12-310001019056-09-000360EDGAR—
2008-03-312007-12-310001019056-08-000469EDGAR—
2007-04-022006-12-310001019056-07-000317EDGAR—
2006-04-182005-12-310001169232-06-001971EDGAR—
2005-04-222004-12-310001169232-05-002255EDGAR—
2004-03-302003-12-310001169232-04-001961EDGAR—
2003-03-312002-12-310001169232-03-002428EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2011-11-142011-09-300001019056-11-001087EDGAR28K words
2011-08-092011-06-300001019056-11-000773EDGAR—
2011-05-132011-03-310001019056-11-000540EDGAR—
2010-11-122010-09-300001019056-10-001246EDGAR—
2010-08-132010-06-300001019056-10-001027EDGAR—
2010-05-112010-03-310001019056-10-000616EDGAR—
2009-11-122009-09-300001019056-09-001110EDGAR—
2009-08-132009-06-300001019056-09-000819EDGAR—
2009-05-122009-03-310001019056-09-000554EDGAR—
2008-11-132008-09-300001019056-08-001310EDGAR—
2008-07-312008-06-300001019056-08-000969EDGAR—
2008-05-152008-03-310001019056-08-000642EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-01-260001493152-26-003615EDGAR19K words
2026-01-230001493152-26-003302EDGAR—
2025-08-070001641172-25-022513EDGAR—
2025-07-010001641172-25-017303EDGAR—
2024-07-180001493152-24-028308EDGAR—
2024-06-050001493152-24-022735EDGAR—
2024-03-250001493152-24-011110EDGAR—
2024-01-020001493152-24-000035EDGAR—
2023-11-280001493152-23-042822EDGAR—
2023-10-270001493152-23-038564EDGAR—

153 total filings indexed. 121 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Tags

hospital-and-radiology-imaging-centers-(approximately-8,500-in-the-us) international-medical-device-market-(10,000-14,000-potential-users) critical-care-and-fluid-management nuclear-medicine-and-blood-volume-diagnostics cryobanking-services clia-medium-complexity-rating fda-marketing-clearance-(bva-100,-1997;-volumex,-1998) cpt-codes-(six-separate-codes-for-blood-volume-measurement) medicare-reimbursement-approval

Company Identity

CIK0000027367
TickerDXR
ExchangeNasdaq
SIC—: —
IncorporatedNY
HeadquartersNew York, NY
Websitehttps://www.daxor.com
Listed1983-07-25

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 07f95e0c5a17cef2d47156d8c44decffdf01b228641dfdc262eae051fa3f7206
parent: 8f7c86594acb4e3e2a6194a372abc896515a76cab300d57cf08f0eee005c6964
content hash: ee8e5befaf49060b11c8fd30bfd9071b86960afb5d543b0e921cf4a3d17fd35c
signed: 2026-06-02T19:00:55.695Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf